Corporate Fact Sheet

Company Overview Customers

Bilcare Research (BSE: BIL, CODE: 526853) is one of the world’s Bilcare Research caters to over 500 pharmaceutical companies
leading providers of integrated solutions to the global pharmaceutical worldwide, including the following, among others:
industry. Our sole focus is to fulfill the unmet needs of the
pharmaceutical industry in the areas of packaging, clinical trial supplies
and brand protection and management. We endeavor to enhance
people’s lives by helping pharmaceutical companies accelerate drug
development lifecycles and combat counterfeit drugs. With a strong
R&D and manufacturing base, we develop end-to-end, innovative and
cost effective solutions for the entire pharmaceutical value chain.

Our Businesses
 Pharmal Packaging Innovations (PPI)
 Global Clinical Supplies (GCS)
 Bilcare Technologies

Global Footprint
United Kingdom
 Clinical trial services facility Strategy
 MHRA approved site
Bilcare Research maintains a defined focus on meeting the challenges
USA faced by the global pharmaceutical industry. We will continue to drive
 Clinical trial services facility innovation in developing packaging solutions to address the
 14 acre FDA & DEA approved site stagnating sales of existing brands in the market place and bolstering
 Films & foils secondary production the drug discovery pipeline through clinical service solutions.

India
 Films & foils production Board of Directors as on September 30, 2009
 Clinical trial services facility – 1st in Asia
 Mohan Bhandari  Dr. Arthur Carty
 Research facilities – DSIR approved
 Award winning – OPPI “Best Vendor” consecutively  Dr. Praful Naik  Rajendra Tapadia
 Dr. Kalyani Gandhi  Dr. Bhojraj Suresh
Singapore
 Dr. Volker Huelck  Dr. R V Chaudhari
 Films production & research centre
 Chandra Prakash Jaggi
 Clinical trial services facility
 Pioneer Status from Singapore Govt.

Financial Performance
Bilcare’s Competitive Edge
The company registered a growth of 40.9% in its consolidated net
 Leading provider of research-driven packaging solutions profit for the year ended March 2010, at Rs.116.87 crore as against
 Comprehensive and innovative product portfolio Rs. 82.94 crore for the corresponding previous year. Consolidated
 State-of-the-art, award winning research and manufacturing sales for the year ended March 31, 2010 stood at Rs. 1047.48 crore
facilities as against Rs. 856.02 crore of previous year, recording a growth of
 Global footprint with operations in Singapore, U.S., UK, 22.36%.
Germany and India
 A reputation for excellence in quality and customer service
 Unrivalled performance servicing the requirements of the
entire pharmaceutical value chain

Bilcare Corporate Fact Sheet.

© 2009, Bilcare Limited. All Rights Reserved. Page 1 of 2
 Research & Operations Regional Offices Representative Offices

Bilcare Singapore Pte. Ltd. Bilcare Argentina

52 Changi South Street 1 Room 701, No.89 Xing Tai Road Bangladesh
Singapore 486161 Baiyu District, Guangzhou
Chile
direct-sg@bilcare.com direct-ch@bilcare.com
Colombia
Bilcare Limited Bilcare GmbH Czech Republic
1028 Shiroli, Rajgurunagar Industriepark Höchst
Egypt
Pune 410505 65926 Frankfurt Main
France
direct-in@bilcare.com direct-eu@bilcare.com
Indonesia
Bilcare Marketing America Latina Ltda. Iran
Bilcare Inc
Alameda Campinas 834 - Apto 111
300 Kimberton Road Israel
Jardim Paulista - CEP:01404-001
Phoenixville PA 19460 Jordan
Sao Paulo
direct-us@bilcare.com
direct-br@bilcare.com Korea
Malaysia
Bilcare GCS (Europe) Ltd Bilcare Mexico
Waller House, 5-Eurong Street, Wahroonga,
Pakistan
Elvicta Business Park, NSW 2076 Sydney
Saudi Arabia
Crickhowell direct-au@bilcare.com
Powys NP8 1DF UK. South Africa
direct-europe@bilcare.com Spain
Taiwan
Thailand
Turkey
Venezuela
Vietnam

© 2009, Bilcare Limited. All Rights Reserved.

FORWARD LOOKING STATEMENTS: This fact sheet is neither an offer nor solicitation to buy or sell any securities mentioned and is for educational
purposes only. While it is believed all sources of information are factual and reliable, in no way is it represented or guaranteed that the description or
statements herein are accurate and complete. The reader should verify all claims and do his/her/their own due diligence before investing in any
securities mentioned. Any forward-looking statements involve risks and uncertainties. Bilcare Research does not undertake any obligation to update any
forward looking statement, except as required under applicable law. This work may not be used, sold, transferred, adapted, abridged, copied or
reproduced in whole on or in part in any manner or form or in any media without the prior written consent of Bilcare Limited. All product names and
company names and logos mentioned herein are the trademarks or registered trademarks of their respective owners.

Bilcare Corporate Fact Sheet.

© 2009, Bilcare Limited. All Rights Reserved. Page 2 of 2